共 5 条
[1]
[Anonymous], Pfizer and BioNTech Initiate Phase 1 Study of Single Dose mRNA-Based Combination Vaccine Candidate for Influenza and COVID-19
[2]
[Anonymous], 2019, CAUSALITY ASSESSMENT, V2nd
[3]
[Anonymous], Coronavirus en Colombia
[4]
Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021
[J].
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT,
2021, 70 (39)
:1379-1384
[5]
Dermatology patients on biologics and certain other systemic therapies should receive a "booster'' messenger RNA COVID-19 vaccine dose: A critical appraisal of recent Food and Drug Administration and Advisory Committee on Immunization Practices recommendations
[J].
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY,
2021, 85 (05)
:1113-1116